Mr. Wilkinson has accepted the position of president and CEO at Impax Laboratories. He was appointed president of Actavis Global R&D in January.
Actavis develops and manufactures pharmaceutical products. The company’s North American branded pharmaceuticals business is focused primarily on women’s health, urology, gastroenterology and dermatology.
More Articles on Gastroenterology:
9 Statistics on Gastroenterologist Compensation by Location
AGA Calls for More Transparency From CMS
The Growing Role of Biologics in Gastroenterology
